Announcements Trials
Browse Landscape

Status

Completed 2Withdrawn 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Lung Neoplasms 4Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Depression 2Vulvar Neoplasms 1Vomiting 1Stomach Neoplasms 1Patient Compliance 1Pancreatic Neoplasms 1Non-resectable Metastatic Cancer of the Lung 1Neuroblastoma 1Nausea 1Leukemia 1Laryngeal Diseases 1Hematologic Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anxiety Disorders 1Anus Neoplasms 1

Interventions

pembrolizumab 8Paclitaxel 8Carboplatin 6niraparib 3Megestrol Acetate 3Cisplatin 3tislelizumab 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2rucaparib 2olaparib 2iso-sulfan blue 2copanlisib 2Taxes 2Surveys and Questionnaires 2Nivolumab 2Lymph Node Excision 2Indocyanine Green 2Fulvestrant 2Filgrastim 2Doxorubicin 2Docetaxel 2tremelimumab 1spartalizumab 1sonidegib 1ribociclib 1rebastinib 1pemigatinib 1nicotinamide-beta-riboside 1lenvatinib 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Endometrial Neoplasms × Interviews as Topic × Clear all
NCT00394602 2020-01-02

Chemoradiation-Induced Nausea and Emesis: Quality of Life

M.D. Anderson Cancer Center

Terminated
207 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Nausea, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡